AMENDMENT NO. 1 TO TRANSACTION AGREEMENTTransaction Agreement • November 29th, 2022 • Viatris Inc • Pharmaceutical preparations
Reference is hereby made to that certain Transaction Agreement, dated as of February 27, 2022 (as amended from time to time, the “Agreement”), by and between Biocon Biologics Limited, a public limited company incorporated under the Indian Companies Act, 2013 (“Buyer”), and Viatris Inc., a Delaware corporation (“Seller Parent”). Capitalized terms used but not defined in this Amendment No. 1 to the Transaction Agreement (this “Amendment”) shall have the respective meanings assigned to them in the Agreement.
